181 related articles for article (PubMed ID: 32990630)
1. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial.
Hochstatter KR; Hull SJ; Sethi AK; Burns ME; Mundt MP; Westergaard RP
J Med Internet Res; 2020 Sep; 22(9):e19703. PubMed ID: 32990630
[TBL] [Abstract][Full Text] [Related]
2. Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study.
Westergaard RP; Hull SJ; Merkow A; Stephens LK; Hochstatter KR; Olson-Streed HK; Baker LM; Hess TM
JMIR Res Protoc; 2016 Jan; 5(1):e15. PubMed ID: 26800903
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
5. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
6. Effect of an mHealth Intervention on Hepatitis C Testing Uptake Among People With Opioid Use Disorder: Randomized Controlled Trial.
Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Cody O; Maus A; Shah DV; Westergaard RP
JMIR Mhealth Uhealth; 2021 Feb; 9(2):e23080. PubMed ID: 33616545
[TBL] [Abstract][Full Text] [Related]
7. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
8. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
Platt L; Minozzi S; Reed J; Vickerman P; Hagan H; French C; Jordan A; Degenhardt L; Hope V; Hutchinson S; Maher L; Palmateer N; Taylor A; Bruneau J; Hickman M
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012021. PubMed ID: 28922449
[TBL] [Abstract][Full Text] [Related]
9. A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial.
Hochstatter KR; Gustafson DH; Landucci G; Pe-Romashko K; Maus A; Shah DV; Taylor QA; Gill EK; Miller R; Krechel S; Westergaard RP
JMIR Res Protoc; 2019 Aug; 8(8):e12620. PubMed ID: 31373273
[TBL] [Abstract][Full Text] [Related]
10. Differential risks of syringe service program participants in Central Ohio: a latent class analysis.
Moon KJ; Bryant I; Trinh A; Hasenstab KA; Carter B; Barclay R; Nawaz S
Harm Reduct J; 2023 Jul; 20(1):97. PubMed ID: 37507721
[TBL] [Abstract][Full Text] [Related]
11. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.
Bartholomew TS; Feaster DJ; Patel H; Forrest DW; Tookes HE
J Subst Abuse Treat; 2021 Aug; 127():108344. PubMed ID: 34134863
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in overdose training, naloxone possession, and naloxone administration among clients and nonclients of a syringe services program.
Jones AA; Park JN; Allen ST; Schneider KE; Weir BW; Hunt D; Sherman SG
J Subst Abuse Treat; 2021 Oct; 129():108412. PubMed ID: 34080560
[TBL] [Abstract][Full Text] [Related]
13. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
[TBL] [Abstract][Full Text] [Related]
14. Preliminary Efficacy of a Theory-Informed Intervention to Increase COVID-19 Testing Uptake Among People Who Inject Drugs in San Diego County: Findings From a Pilot Randomized Controlled Trial.
Bazzi AR; Abramovitz D; Harvey-Vera A; Stamos-Buesig T; Vera CF; Artamonova I; Logan J; Patterson TL; Strathdee SA
Ann Behav Med; 2023 May; 57(6):472-482. PubMed ID: 37029714
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study.
Barocas JA; Brennan MB; Hull SJ; Stokes S; Fangman JJ; Westergaard RP
Harm Reduct J; 2014 Jan; 11():1. PubMed ID: 24422784
[TBL] [Abstract][Full Text] [Related]
16. Injecting Alone: Practices and Preferences among People Who Inject Drugs in New York City.
Riback L; Pérez-Correa AE; Ghiroli MM; López-Castro T; Fox AD
Subst Use Misuse; 2022; 57(13):1988-1996. PubMed ID: 36151968
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
[TBL] [Abstract][Full Text] [Related]
18. Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study.
Roux P; Rojas Castro D; Ndiaye K; Debrus M; Protopopescu C; Le Gall JM; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri P
PLoS One; 2016; 11(6):e0157062. PubMed ID: 27294271
[TBL] [Abstract][Full Text] [Related]
19. Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV Prevention.
Mateu-Gelabert P; Guarino H; Quinn K; Meylakhs P; Campos S; Meylakhs A; Berbesi D; Toro-Tobón D; Goodbody E; Ompad DC; Friedman SR
Curr HIV/AIDS Rep; 2018 Aug; 15(4):324-335. PubMed ID: 29931468
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree.
Ijioma SC; Pontinha VM; Holdford DA; Carroll NV
J Manag Care Spec Pharm; 2021 Feb; 27(2):137-146. PubMed ID: 33506729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
